TheraRadar

Competitive Density

Active trials by therapeutic area and indication

Density Legend (based on active Phase 3 trials & sponsor count)
Hot (crowded)
Warm (competitive)
Cool (moderate)
Cold (sparse)

Oncology

22187 active trials
Solid Tumor (Advanced)
Ph3: 330 • Ph2: 1748 • 15 sponsors
Breast Cancer
Ph3: 296 • Ph2: 858 • 15 sponsors
NSCLC
Ph3: 268 • Ph2: 875 • 15 sponsors
Colorectal Cancer
Ph3: 177 • Ph2: 714 • 15 sponsors
Non-Hodgkin Lymphoma
Ph3: 163 • Ph2: 944 • 15 sponsors
ALL
Ph3: 152 • Ph2: 620 • 15 sponsors
Prostate Cancer
Ph3: 152 • Ph2: 538 • 15 sponsors
Multiple Myeloma
Ph3: 104 • Ph2: 397 • 15 sponsors
Hepatocellular Carcinoma
Ph3: 92 • Ph2: 379 • 15 sponsors
Bladder Cancer
Ph3: 85 • Ph2: 272 • 15 sponsors
Esophageal Cancer
Ph3: 81 • Ph2: 299 • 15 sponsors
Gastric Cancer
Ph3: 80 • Ph2: 319 • 15 sponsors
AML
Ph3: 75 • Ph2: 352 • 15 sponsors
Lung Cancer (General)
Ph3: 75 • Ph2: 343 • 15 sponsors
Ovarian Cancer
Ph3: 74 • Ph2: 293 • 15 sponsors
Pancreatic Cancer
Ph3: 71 • Ph2: 413 • 15 sponsors
Melanoma
Ph3: 59 • Ph2: 300 • 15 sponsors
Hematologic Malignancies
Ph3: 55 • Ph2: 311 • 15 sponsors
SCLC
Ph3: 54 • Ph2: 195 • 15 sponsors
Head and Neck Cancer
Ph3: 51 • Ph2: 334 • 15 sponsors
Cervical Cancer
Ph3: 45 • Ph2: 179 • 15 sponsors
Neuroendocrine Tumors
Ph3: 45 • Ph2: 115 • 15 sponsors
Sarcoma
Ph3: 41 • Ph2: 326 • 15 sponsors
Triple Negative Breast Cancer
Ph3: 39 • Ph2: 206 • 15 sponsors
Brain Tumor
Ph3: 37 • Ph2: 171 • 15 sponsors
CLL
Ph3: 35 • Ph2: 136 • 15 sponsors
Renal Cell Carcinoma
Ph3: 33 • Ph2: 168 • 15 sponsors
Squamous Cell Carcinoma
Ph3: 33 • Ph2: 227 • 15 sponsors
MDS
Ph3: 32 • Ph2: 221 • 15 sponsors
Endometrial Cancer
Ph3: 32 • Ph2: 136 • 15 sponsors
Glioblastoma
Ph3: 30 • Ph2: 201 • 15 sponsors
Cholangiocarcinoma
Ph3: 28 • Ph2: 195 • 15 sponsors
HER2+ Breast Cancer
Ph3: 24 • Ph2: 66 • 15 sponsors
Hodgkin Lymphoma
Ph3: 18 • Ph2: 158 • 15 sponsors
Thyroid Cancer
Ph3: 18 • Ph2: 60 • 15 sponsors
Myelofibrosis
Ph3: 17 • Ph2: 68 • 15 sponsors
HER2- Breast Cancer
Ph3: 15 • Ph2: 76 • 15 sponsors
CML
Ph3: 9 • Ph2: 77 • 15 sponsors
Merkel Cell Carcinoma
Ph3: 4 • Ph2: 36 • 15 sponsors
Mesothelioma
Ph3: 3 • Ph2: 52 • 15 sponsors

Hot = Crowded space, many late-stage competitors

Cold = Less competition, potential opportunity or difficult indication